earnings
PA
NASDAQ · PACB
Pacific Biosciences of California, Inc.
Healthcare · Medical - Devices
$1.35
Up+$0.12 (+9.76%)
Updated Aug 22, 2026, 2:51 AM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 652.12M
- P/E ratio
- -1.29
- Dividend yield
- 0.00%
- 52-week range
- $1.07 – $2.73
- Volume
- 7.12M
- Avg. volume
- 9M
Price performance
PACB price history
1M range · 21 trading sessions · Daily adjusted prices
PACB closed at $1.35 after 21 trading sessions, down 0.74% for the selected period.
- Last close
- $1.35
- Period change
- -0.74%
- Period low
- $1.11
- Period high
- $1.48
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $1.24 | $1.38 | $1.22 | $1.35 | 7.12M |
| Aug 20, 2026 | $1.26 | $1.32 | $1.22 | $1.23 | 4.76M |
| Aug 19, 2026 | $1.20 | $1.31 | $1.20 | $1.27 | 10.91M |
| Aug 18, 2026 | $1.19 | $1.205 | $1.12 | $1.14 | 4.82M |
| Aug 17, 2026 | $1.15 | $1.225 | $1.13 | $1.21 | 6.12M |
| Aug 14, 2026 | $1.15 | $1.18 | $1.125 | $1.15 | 3.93M |
| Aug 13, 2026 | $1.13 | $1.18 | $1.10 | $1.15 | 6.35M |
| Aug 12, 2026 | $1.15 | $1.16 | $1.07 | $1.11 | 13.3M |
| Aug 11, 2026 | $1.17 | $1.17 | $1.14 | $1.14 | 6.12M |
| Aug 10, 2026 | $1.16 | $1.19 | $1.12 | $1.15 | 7.84M |
| Aug 7, 2026 | $1.19 | $1.23 | $1.165 | $1.185 | 7.38M |
| Aug 6, 2026 | $1.30 | $1.31 | $1.15 | $1.165 | 14.53M |
| Aug 5, 2026 | $1.44 | $1.465 | $1.27 | $1.30 | 11.64M |
| Aug 4, 2026 | $1.44 | $1.47 | $1.41 | $1.44 | 6.4M |
| Aug 3, 2026 | $1.43 | $1.47 | $1.395 | $1.42 | 3.55M |
| Jul 31, 2026 | $1.47 | $1.48 | $1.39 | $1.40 | 3.14M |
| Jul 30, 2026 | $1.41 | $1.49 | $1.41 | $1.48 | 2.81M |
| Jul 29, 2026 | $1.38 | $1.47 | $1.38 | $1.40 | 7.34M |
| Jul 28, 2026 | $1.35 | $1.415 | $1.32 | $1.39 | 7.93M |
| Jul 27, 2026 | $1.36 | $1.41 | $1.34 | $1.36 | 6.75M |
| Jul 24, 2026 | $1.42 | $1.43 | $1.32 | $1.36 | 8.06M |
Latest PACB news
The latest Smart Investors Daily articles mentioning PACB.
Stock researchResearch & News · SEC Filings
Loading stock research…